CliffBio
small molecule

MINOCIN

MINOCYCLINE HYDROCHLORIDE

Loss of exclusivityOctober 2032latest FDA-listed patent expiry
CompanyREMPEX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF MELINTA THERAPEUTICS LLC

Drug detail

Brand nameMINOCIN
Active ingredientMINOCYCLINE HYDROCHLORIDE
StrengthEQ 100MG BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusRX

Listed patents

PatentExpiresType
11944634October 2032product
9084802May 2031use U-282
9278105May 2031use U-282
12161656May 2031product

More from REMPEX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF MELINTA THERAPEUTICS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MINOCIN patent cliff — loss of exclusivity October 2032 | CliffBio